Biospecimen Core
生物样本核心
基本信息
- 批准号:10224122
- 负责人:
- 金额:$ 29.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-17 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AutopsyBioinformaticsBiological AssayBiological MarkersBiological Specimen BanksBiometryBloodBlood specimenBrain NeoplasmsCaringCell LineCellsCerebrospinal FluidClinicalClinical ResearchCollectionConsentConsultationsCryopreservationDNADataDatabasesDevelopmentDiagnosticEngraftmentEnsureEquipment and supply inventoriesEvaluationFreezingFundingGenesGliomaHistologicHospitalsHuman ResourcesImmunocompromised HostIndividualInstitutionLaboratory ResearchLymphocyteMalignant NeoplasmsMalignant neoplasm of brainMicroscopyModelingMolecularMolecular ProfilingMusMutationNormal tissue morphologyOperating RoomsOperative Surgical ProceduresParaffin EmbeddingPathologicPatientsPatternPlasmaProceduresPromegaProtocols documentationQuality ControlRNA analysisRecurrenceResearchResearch PersonnelResearch SupportResistanceResourcesSamplingSecureServicesShort Tandem RepeatSourceSpecimenSupervisionTestingTherapeuticTimeTissue SampleTissuesTranslationsTumor Tissuebasebiobankcancer stem cellcell free DNAclinical translationexperiencefollow-upimprovedinnovationinterestlight microscopyneoplastic cellnext generation sequencingpatient derived xenograft modelrepositorystem cell modeltherapy outcometranscriptome sequencingtranscriptomicstranslational approachtumortumor registry
项目摘要
BIOSPECIMEN CORE: SUMMARY
The Biospecimen Core is a vital resource that supports all brain tumor research at Northwestern, and is
especially important in seeing that all projects experience clinical translation within the period of SPORE
funding. Regular interactions with the Biostatistics & Bioinformatics Core and Administrative Core will ensure
that each project achieves its objectives, and has positive impact on the care of brain tumor patients.
The Biospecimen Core will have extensive interactions with all projects and cores by acting as the central
repository of patient tissues and renewable tumor resources, by providing the highest quality of tissue
analytical services, and by providing neuropathological consultation. The Director of the Core, Dr. Horbinski, as
well as the Co-Director, Dr. Daniel Brat, will supervise quality control testing of banked specimens, and will
perform all microscopy-based analyses of patient tissues and tumor models for each SPORE project.
Biospecimen Core activities will be performed to accomplish the following aims:
Aim 1: Provide Northwestern brain tumor researchers with annotated biospecimens from brain tumor
patients.
Aim 2: Subject all biospecimens to rigorous quality control.
Aim 3: Propagate, bank, and characterize surgical specimen derivatives, including PDX and cancer
stem cell (CSC) models, to meet ongoing needs for renewable tumor cell sources.
Aim 4: Support SPORE projects with biospecimens and neuropathologic analyses.
生物样本核心:总结
生物标本核心是支持西北大学所有脑肿瘤研究的重要资源,
尤其重要的是,要确保所有项目都在SPORE期间经历临床翻译
经费与生物统计学和生物信息学核心和行政核心的定期互动将确保
每个项目都能达到其目标,并对脑肿瘤患者的护理产生积极的影响。
生物标本核心将作为中心,与所有项目和核心进行广泛的互动,
通过提供最高质量的组织,
分析服务,并提供神经病理咨询。核心主任Horbinski博士,作为
以及联合主任丹尼尔布拉特博士,将监督库存标本的质量控制测试,并将
对每个SPORE项目的患者组织和肿瘤模型进行所有基于显微镜的分析。
将开展生物样本核心活动,以实现以下目标:
目的1:为西北脑肿瘤研究者提供脑肿瘤的注释生物标本
患者
目标2:对所有生物标本进行严格的质量控制。
目标3:鉴定、储存和表征手术标本衍生物,包括PDX和癌症
干细胞(CSC)模型,以满足对可再生肿瘤细胞来源的持续需求。
目标4:通过生物标本和神经病理学分析支持SPORE项目。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Craig Michael Horbinski其他文献
Craig Michael Horbinski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Craig Michael Horbinski', 18)}}的其他基金
Targeting IDH mutations to improve seizure control in glioma patients
针对 IDH 突变改善神经胶质瘤患者的癫痫发作控制
- 批准号:
10398216 - 财政年份:2020
- 资助金额:
$ 29.48万 - 项目类别:
Targeting IDH mutations to improve seizure control in glioma patients
针对 IDH 突变改善神经胶质瘤患者的癫痫发作控制
- 批准号:
10226923 - 财政年份:2020
- 资助金额:
$ 29.48万 - 项目类别:
Interaction between Tissue Factor, Junctional Adhesion Molecule-A, and Integrin B1 to drive self-renewal in glioblastoma
组织因子、连接粘附分子 A 和整合素 B1 之间的相互作用驱动胶质母细胞瘤的自我更新
- 批准号:
10331881 - 财政年份:2020
- 资助金额:
$ 29.48万 - 项目类别:
Interaction between Tissue Factor, Junctional Adhesion Molecule-A, and Integrin B1 to drive self-renewal in glioblastoma
组织因子、连接粘附分子 A 和整合素 B1 之间的相互作用驱动胶质母细胞瘤的自我更新
- 批准号:
10554404 - 财政年份:2020
- 资助金额:
$ 29.48万 - 项目类别:
Targeting IDH mutations to improve seizure control in glioma patients
针对 IDH 突变改善神经胶质瘤患者的癫痫发作控制
- 批准号:
10044076 - 财政年份:2020
- 资助金额:
$ 29.48万 - 项目类别:
Targeting IDH mutations to improve seizure control in glioma patients
针对 IDH 突变改善神经胶质瘤患者的癫痫发作控制
- 批准号:
10612395 - 财政年份:2020
- 资助金额:
$ 29.48万 - 项目类别:
Tissue Factor as a Key Determinant of IDH1 Mutant versus IDH1 Wild-type Glioma Thrombosis and Malignancy
组织因子是 IDH1 突变型与 IDH1 野生型胶质瘤血栓形成和恶性肿瘤的关键决定因素
- 批准号:
10197235 - 财政年份:2017
- 资助金额:
$ 29.48万 - 项目类别:
Tissue Factor as a Key Determinant of IDH1 Mutant versus IDH1 Wild-type Glioma Thrombosis and Malignancy
组织因子是 IDH1 突变型与 IDH1 野生型胶质瘤血栓形成和恶性肿瘤的关键决定因素
- 批准号:
9980502 - 财政年份:2017
- 资助金额:
$ 29.48万 - 项目类别:
相似海外基金
Conference: Global Bioinformatics Education Summit 2024 — Energizing Communities to Power the Bioeconomy Workforce
会议:2024 年全球生物信息学教育峰会 — 激励社区为生物经济劳动力提供动力
- 批准号:
2421267 - 财政年份:2024
- 资助金额:
$ 29.48万 - 项目类别:
Standard Grant
Open Access Block Award 2024 - EMBL - European Bioinformatics Institute
2024 年开放获取区块奖 - EMBL - 欧洲生物信息学研究所
- 批准号:
EP/Z532678/1 - 财政年份:2024
- 资助金额:
$ 29.48万 - 项目类别:
Research Grant
Conference: The 9th Workshop on Biostatistics and Bioinformatics
会议:第九届生物统计与生物信息学研讨会
- 批准号:
2409876 - 财政年份:2024
- 资助金额:
$ 29.48万 - 项目类别:
Standard Grant
PAML 5: A friendly and powerful bioinformatics resource for phylogenomics
PAML 5:用于系统基因组学的友好且强大的生物信息学资源
- 批准号:
BB/X018571/1 - 财政年份:2024
- 资助金额:
$ 29.48万 - 项目类别:
Research Grant
PDB Management by The Research Collaboratory for Structural Bioinformatics
结构生物信息学研究合作实验室的 PDB 管理
- 批准号:
2321666 - 财政年份:2024
- 资助金额:
$ 29.48万 - 项目类别:
Cooperative Agreement
Building a Bioinformatics Ecosystem for Agri-Ecologists
为农业生态学家构建生物信息学生态系统
- 批准号:
BB/X018768/1 - 财政年份:2023
- 资助金额:
$ 29.48万 - 项目类别:
Research Grant
Integrative viral genomics and bioinformatics platform
综合病毒基因组学和生物信息学平台
- 批准号:
MC_UU_00034/5 - 财政年份:2023
- 资助金额:
$ 29.48万 - 项目类别:
Intramural
Collaborative Research: IIBR: Innovation: Bioinformatics: Linking Chemical and Biological Space: Deep Learning and Experimentation for Property-Controlled Molecule Generation
合作研究:IIBR:创新:生物信息学:连接化学和生物空间:属性控制分子生成的深度学习和实验
- 批准号:
2318829 - 财政年份:2023
- 资助金额:
$ 29.48万 - 项目类别:
Continuing Grant
Planning Proposal: CREST Center in Bioinformatics
规划方案:CREST生物信息学中心
- 批准号:
2334642 - 财政年份:2023
- 资助金额:
$ 29.48万 - 项目类别:
Standard Grant